Clinical Trials Directory

Trials / Unknown

UnknownNCT02020954

Prospective Becker-Heart-Study

Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Karim WAHBI · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether electrocardiogram, echocardiography, cardiac MRI, sera biomarkers can improve early detection of myocardial involvement and clinical outcome.

Detailed description

A cohort of 100 patients with mutations in the dystrophin gene associated with Becker muscular dystrophy and/or dilated cardiomyopathy will be included (patients with Duchenne muscular dystrophy are excluded). Patients with undergo at baseline the following workups: electrocardiogram, echocardiography, cardiac MRI, sera biomarkers measurement. At 3 years and 5 years, patients will be investigated according to the same protocol and occurrence of cardiac adverse events in the meanwhile will be recorded. Statistical analysis will assess correlations between cardiac phenotype and DMD mutations and prognostic value of cardiac investigations.

Conditions

Interventions

TypeNameDescription
PROCEDUREECG, echocardiography, cardiac MRI, sera biomarkers

Timeline

Start date
2013-01-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2013-12-25
Last updated
2015-03-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02020954. Inclusion in this directory is not an endorsement.